Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery (“MIS”), announces that its wholly owned subsidiary, Elemental Healthcare Limited, has signed a three year exclusive UK distribution agreement with DistalMotion SA, a Swiss manufacturer of a new surgical robot.
The ‘Dexter’ robot brings a totally new dimension to the clinical efficacy of robotic surgery, allowing a surgeon to swap from robotic to laparoscopic surgery and back as required within the sterile field. ‘Dexter’ will be CE marked in mid-2019 giving Elemental Healthcare time to train a dedicated team in preparation for its launch.
Adam Power, Group Development Director of Surgical Innovations Group plc, commented: The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate. ‘Dexter’ offers a much broader range of surgical opportunites and employs a novel funding model. As a consequence, we expect ‘Dexter’ by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals.
Dr Matthias Reif, Head of Sales and Marketing of DistalMotion SA commented: Elemental Healthcare is a proven partner to commercialize innovative technology, and we are excited to partner as we believe this is the best route to commercialize ‘Dexter’. The UK market is among the largest medical device markets in Europe, and a key region for Distalmotion to prove robotic surgery can be simplified and integrated into laparoscopic surgery.